QQ客服 官方微博 反馈留言

	A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Mullerian hormone signaling pathway
	Li, Lin; Zhou, Xueya; Wang, Xi; Wang, Jing; Zhang, Wei; Wang, Binbin; Cao, Yunxia; Kee, Kehkooi
	2016
卷号	22期号:9页码:669-678
关键词	primary ovarian insufficiency anti-Mullerian hormone (AMH) AMHR2 dominant negative mutation signaling pathway granulosa cell transforming growth factor-beta (TGF-beta) premature ovarian failure ovarian follicle development
ISSN号	1360-9947
DOI	10.1093/molehr/gaw040
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6381787
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Li, Lin,Zhou, Xueya,Wang, Xi,et al. A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Mullerian hormone signaling pathway[J],2016,22(9):669-678.
APA	Li, Lin.,Zhou, Xueya.,Wang, Xi.,Wang, Jing.,Zhang, Wei.,...&Kee, Kehkooi.(2016).A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Mullerian hormone signaling pathway.,22(9),669-678.
MLA	Li, Lin,et al."A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Mullerian hormone signaling pathway".22.9(2016):669-678.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。